Nachrichten zur Hims & Hers Health Aktie

FDA to restrict GLP-1 ingredients used in non?approved compounded drugs

The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims…

FDA to Restrict Copycat Weight Loss Drugs Sold by Pharma Rivals

The US Food and Drug Administration said it would crack down on copycat weight loss drugs like those marketed by…

FDA to restrict GLP-1 ingredients used in non?approved compounded drugs

The U.S. Food and Drug Administration said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs…

Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill

Hims & Hers also said it’s selling a cancer-detection test that’s featured in its Super Bowl ad, which plays like…

Hims $49 weight-loss pill rattles investor case for cash-pay obesity market

Hims & Hers gambit to sell a $49 compounded version of Novo Nordisks Wegovy pill is rattling obesity shares, sparking…

Hims & Hers shares tick lower after Novos legal threat

Hims & Hers stock ticked lower Friday after Novo Nordisk said its newly announced Wegovy pill copy was illegal and…

FDAs Makary pledges crackdown on mass marketing of illegal copycat drugs in wake of Hims Wegovy pill push

With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the…

Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill

Novo Nordisk has also spoken out strongly against Hims & Hers compounded Wegovy pill, with CEO Maziar Mike Doustdar telling…

Hims & Hers Stock Tanks. It May Be Losing Its Weight-Loss Battle With Novo.

Novo Nordisk stock has dived this week, dragged down by a weak sales outlook and the launch of a Wegovy…

Hims & Hers falls 8% after Novos legal threat. Heres the latest

Hims & Hers stock fall to a 12-month low after Novo said its $49 Wegovy pill copy was "illegal"…

FDA targets illegal drug copies amid latest Hims & Hers/Novo Nordisk flashpoint

FDA commissioner Marty Makary’s pledge came after Hims & Hers launched a compounded version of Novo’s Wegovy pill.…

Leerink Partners reiterates Market Perform rating on Hims & Hers stock By Investing.com

Leerink Partners reiterates Market Perform rating on Hims & Hers stock…

Hims & Hers $49 weight-loss pill jolts everyone, except its stock

Hims & Hers sent a shockwave through the pharmaceutical industry on Thursday with its announcement of a weight-loss pill with…

Hims & Hers $49 Weight-Loss Pill Jolts Everyone, Except Its Stock

NEW YORK, Feb 6 (Reuters) - Hims & Hers sent a shockwave through the pharmaceutical industry on ?Thursday with its…

Novo Nordisk to sue Hims & Hers over illegal compounding

Danish drugmakers Novo Nordisk’s shares fell more than 8% on Thursday after Hims & Hers announced that it would be…

Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers Stocks

Hims & Hers Health, Eli Lilly, and Novo Nordisk shares all slid Thursday after Hims & Hers said it would…

Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill

Hims & Hers is making available a cheaper, compounded version of the Wegovy weight loss pill sold by Novo Nordisk,…

Novo Nordisk says it will take legal action after Hims & Hers reveals $49 copy of Wegovy pill

Hims said it would sell a copy of the newly launched weight loss pill for $49, far less than the…

Hims And Hers Broadens Care Model With GLP 1 Pill And Cancer Test

Hims & Hers Health (NYSE:HIMS) introduced a low cost compounded semaglutide pill for weight loss, offering a needle free alternative…

Dow falls sharply, Hims Wegovy rival, Nios profit outlook

Yahoo Finance Anchor Josh Lipton tracks todays top moving stocks and biggest market stories in this Market Minute, including the…

Novo Nordisk-Aktie -7%: Hims & Hers Health bringt wohl günstige Wegovy-Kopie - Auch Eli Lilly-Aktie unter Druck

Zuvor hatte die Nachrichtenagentur Reuters berichtet, dass das US-Telemedizinunternehmen Hims & Hers Health eine Nachahmer-Kopie der Abnehmpille Wegovy von Novo…

Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy. The news…

Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy.…

Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy…

Hims & Hers offers cheaper weight-loss pill in a shock to Novo

STORY: Shares of Novo Nordisk plunged again on Thursday after online telehealth firm Hims & Hers said it will offer…

Him & Hers plans to offer cheaper version of Wegovy pill, prompting Novo Nordisk to threaten legal action

A month after drugmaker Novo Nordisk launched its Wegovy pill, online health and wellness company Hims & Hers plans to…

Novo Nordisk klagt – Aktie auf tiefstem Stand seit 5 Jahren

Erst Preisdruck, dann Kurssturz – jetzt folgt die Eskalation. Novo Nordisk kündigt rechtliche Schritte an und geht offen auf Konfrontation…

Novo Nordisk klagt – Aktie auf tiefstem Stand seit 5 Jahren

Erst Preisdruck, dann Kurssturz – jetzt folgt die Eskalation. Novo Nordisk kündigt rechtliche Schritte an und geht offen auf Konfrontation…

Novo Nordisk Accuses Hims & Hers of ‘Illegal Mass Compounding’ Over Cheaper Wegovy Version

Hims & Hers said it would begin offering copies of Wegovy for an introductory price of $49 for the first…

Wegovy Copycat Is Coming From Hims & Hers. Novo Nordisk Stock Falls.

Hims & Hers’ new alternative to Novo Nordisk’s Wegovy pill will sell for $49 for the first month and $99…

Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding

Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online telehealth company said…

Hims & Hers launch of compounded $49 Wegovy pill pummeled Novo Nordisk’s shares

The compounded pill is less expensive than the oral version of Wegovy, which costs $149 to get started.…

Why Eli Lilly Stock Just Dropped

Hims & Hers has a GLP-1 weight loss pill -- and its the cheapest one out there.…

Novo Nordisk hurt as rival Hims & Hers launches cheaper weight-loss pill

US telehealth group will sell product for $49 a month, a third that of its Danish competitor…

Hims & Hers Stock Jumps On Compounded Wegovy Launch - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health shares are trading higher Thursday after the company launched a compounded copy of the Wegovy pill…

VIEW Hims and Hers Healths compounded Wegovy pill offering fuels market jitters

Hims & Hers said it would begin offering compounded versions of Novo Nordisks Wegovy pill at an introductory price of…

Hims Knocks Off Novos Wegovy Pill For Just $49 A Month

Hims & Hers Health launched a knockoff version of Novo Nordisks already popular weight-loss pill on Thursday.…

Hims & Hers confirms $49 monthly starting price for Wegovy pill copy

Hims Hers (HIMS) confirmed that starting today, eligible customers can access treatment plans that include compounded semaglutide pills at…

Hims & Hers reportedly launches copy of Novo’s Wegovy pill

Hims & Hers (HIMS) stock jumps as the company plans to launch cheaper compounded versions of Novo Nodisks (NVO) Wegovy…

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion…

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

SAN FRANCISCO, February 05, 2026--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform,…

Hims & Hers launches compounded semaglutide pill as lower-cost weight loss option

Hims & Hers (NYSE:HIMS) has announced the launch of a compounded semaglutide pill designed for weight loss, providing an alternative…

Hims & Hers copies Novo Nordisks new Wegovy pill

Competition has already arrived for Novo Nordisks Wegovy pill, as telehealth company Hims & Hers launches a compounded version…

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

Hims Hers Health, Inc. (“Hims Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion…

dpa-AFX ProFeed